Genetic data as a signal of changing malaria transmission

Lead Research Organisation: Imperial College London
Department Name: School of Public Health

Abstract

Malaria, an infectious disease spread by mosquitoes, is one of the world's most devastating illnesses. The majority of malaria infections can be found among children living in Africa, where a child dies roughly every minute from malaria. However, in recent years there have been huge advances in malaria control, with the number of yearly deaths due to malaria roughly halving since the year 2000. This is largely the result of increased investment in insecticide treated mosquito nets and effective antimalarial drugs.

As the number of people infected with malaria decreases we face a new challenge - measuring the amount of malaria that remains in a population. Once the majority of the malaria parasites have been eliminated from the population, and the number of people carrying the disease has come down, the remaining cases will tend to be concentrated in a few hard-to-reach groups of individuals. At this point we start to see diminishing returns with ordinary surveillance methods, and it can be difficult to keep track of how much malaria remains. Without accurate measurement we cannot know if antimalarial strategies are working, and it is possible for the disease to bounce back undetected.

One possible way around this problem is to make use of the information held in genetic data. First, individuals suspected of carrying malaria have blood taken and are checked for the malaria parasites (as is usual when diagnosing a case). The DNA of the parasites is also extracted and sent for analysis. Crucially, the level of variation that we observe in the parasite DNA will depend on how much malaria is circulating in the population; if malaria is contained at low levels then we would expect to see very little genetic variation, with all parasites starting to look essentially genetically identical, whereas if malaria is bouncing back to high levels we would expect to see high levels of genetic variation. In this way, genetic data gives us a window into the processes that are occurring in the parasite population without us having to exhaustively sample from every single infected individual in the population.

In my research I will take this relationship between the amount of circulating malaria and the amount of observed genetic variation and turn it into a tool for measuring ongoing levels of transmission. Through mathematical modelling of the malaria life cycle, coupled with modern computational methods, I will design programs that can be used to extract the information present in genetic data, and use this information to estimate the level of infection in a population. Once developed into a user-friendly piece of software, this tool could be used by scientists and policy-makers around the world to make the most of their available data - or to decide whether it is worth the additional cost of collecting new genetic data.

I is my hope that this tool will provide one more line of attack in the struggle to reduce malaria morbidity and mortality globally.

Technical Summary

Malaria is declining on a worldwide scale, with many countries now setting their sites on elimination. A major challenge in the future of malaria control and elimination efforts will be monitoring transmission intensity once prevalence reaches low levels, and hence traditional surveillance methods begin to lose statistical power. Genetic data constitutes a rich and underutilised source of information here. The fact that sexual recombination between genetically distinct strains can only occur when an individual receives multiple infections simultaneously (for example by receiving bites from two separate infectious mosquitoes) means that parasite population genetics are intimately linked to ongoing levels of transmission. The handful of studies that have attempted to infer levels of transmission directly from genetic data have shown promising results, but so far lack generalisability and efficiency.

I will develop the statistical and computational machinery needed to turn these fledgeling ideas into a rigorous methodology. By making use of recent developments in coalescent theory, and further extending these methods to account for recombination, I will create efficient algorithms for simulating genetic data from complex malaria transmission models. I will then use approximate Bayesian computation (ABC) to turn this simulation-based method into an inferential tool, using machine learning techniques to maximise statistical power. Finally, I will dedicate time to accessibility, making sure that newly developed methods are available to a wide audience, and not just those used to dealing with mathematical models.

Planned Impact

My proposed research has the potential to impact on a number of different sectors:

1. Research scientists

The implementation of my research plan will bring together many methods at the cutting edge of coalescent theory, transmission modelling, and statistical inference. I hope to stimulate interest in each of these areas, and in doing so push malaria modelling to the next level. In particular, I hope to encourage exchange of ideas between the fields of population genetics and pure epidemiological modelling, which have historically remained relatively separate. By producing high quality publications and presenting at conferences in both epidemiology and population genetics I hope to bridge this gap.

2. Malaria policy makers

Monitoring changes in malaria transmission is critical to evaluating the cost-effectiveness of interventions, with surveillance highlighted as a central pillar of the Global Strategy for 2016-2030. Investment in genetic markers is increasingly being promoted as an additional tool to understand malaria receptivity in countries approaching elimination. As new tools become available it is crucial that a framework exists for evaluating their utility, and for making decisions on the basis of firm scientific evidence. My research will help to fill this gap by evaluating the potential for genetic data to enhance existing epidemiological surveillance. Further challenges at the country level include identifying imported malaria cases and preventing the spread of resistance to Artemisinin-based combination therapies. Both of these problems involve gene flow between populations, and so the development of an integrated model of malaria transmission and genetics will be an important first step towards tackling these challenges.

3. Programmes supporting field implementation

One of the specific objectives of my project is the creation of a freely available tool for evaluating the potential benefits of genetic information. This tool will complement the existing Malaria Tools program, which was developed by researchers at Imperial College London in collaboration with the World Health Organisation to aid in malaria elimination scenario planning at the country level. The genetic dimension is currently missing from these tools, and this gap will continue to grow as genetic data becomes cheaper and more easily available. This will make it difficult for field programme directors to know whether it is worth investing in genetic analysis, and if they do intend to invest then what sample size is needed to give informative results. By dealing with this issue at an early stage we can identify those areas where new forms of data are likely to be most beneficial, while also discouraging groups from jumping on the latest technology if it will not prove cost-effective.

4. Future researchers

The rapid progress in genetic technologies in recent years has captured the interest of the non-scientific community, and has the potential to inspire a new generation of researchers. The application of these ideas to problems of health and human welfare adds another dimension to this narrative, which is often lacking from perceived theoretical subjects. By bringing together these ideas in a single project, this research cuts across the fields of biology, medicine and mathematics. Through public engagement activities, teaching and supervision I aim to use this work to inspire future researchers and promote interest in this area.

5. Individuals living in P.falciparum endemic countries

Ultimately the tools developed in my research plan have the potential to benefit individuals living in malaria endemic regions. Through careful monitoring of transmission levels as malaria incidence declines, coupled with informed decision-making and prioritisation of cost-effective strategies, we can ensure that the elimination goals of many countries are reached as quickly and efficiently as possible.

Publications

10 25 50
 
Description This award focused on the role of genetics in malaria surveillance and how we might use this non-traditional type of data to increase our understanding of disease transmission. The project ended up touching on several different types of genetic surveillance, some of which were not anticipated at the time of writing the proposal.

Early on in the project it became apparent that some malaria parasites in the Democratic Republic of the Congo (DRC) were developing "stealth" mutations. Unlike classical drug resistance mutations that cause parasites to survive in the presence of antimalarial drugs, these stealth mutations cause parasites to become invisible to detection by rapid tests. In areas that rely heavily on rapid tests this represents a significant public health threat, as epidemics can potentially progress undetected. My analysis found areas with particularly high concentration of these stealth mutations in DRC, and together with colleagues we explored the factors that likely contribute to strong selective pressure. These findings were relayed to the WHO leading to a position document on rapid tests and a plan for future surveillance.

Focusing on more traditional drug resistance, by combining genetic data and advanced spatial techniques myself and colleagues were able to track the spread of drug resistance mutations over space and time in DRC. In particular, we found that mutations conferring resistance to sulfadoxine-pyrimethamine (a common antimalarial drug) have increased in frequency and spatial range in recent years. One particular mutation appears to be spreading East-to-West at a rate of approximately 55km per year. These findings were relayed back to local malaria control programmes.

Finally, new analysis methods allow for more detailed forms of surveillance from genetic data, for example changes in transmission intensity or identification of imported cases. Here, myself and colleagues used simulation methods to explore the value of different types of genetic measures. Promisingly, we found that the most powerful predictors of prevalence in many settings were simple metrics, based on e.g. the number of unique genotypes. At lower transmission this switched to a different type of metric based on relatedness. The latter also had a clear signal with distance that may be useful in classifying imported vs. locally acquired cases.

I believe this project demonstrated some of the value of parasite genetics in malaria surveillance, although there is a long way to go before these methods can be routinely used to assist control programmes. In particular, I only scratched the surface of what is possible from simulation. Through the contacts made during this project I plan to continue working on the core aspiration of using simulation to inform genetic surveillance strategies over the coming years.
Exploitation Route The outputs of this project can be broadly split into published analyses and software. The conclusions of the analyses are relevant and available to anyone working on spatial analysis of parasite genetic data, and all code and data are publicly available. The results around drug and diagnostic resistance should be taken into consideration by anyone seeking to understand optimal control strategies in central Africa. On the software side, the MALECOT package for inferring population structure in the presence of polyclonal infections is live and available for download and use. Similarly, the MIPanalyzer package continues to be a useful tool for anyone working with molecular inversion probe (MIP) data.
Sectors Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

URL https://www.who.int/malaria/publications/atoz/information-note-hrp2-based-rdt/en/
 
Description The results of the hrp2-deletion analysis were relayed to the World Health Organisation (WHO) Malaria Policy Advisory Committee (MPAC) leading to a new position document on malaria rapid diagnostic tests. This has direct implications for control programmes, healthcare and pharmaceutical companies and those involved in the design and manufacture of rapid tests. The results around drug resistance patterns in DRC were relayed directly to representatives of control programmes in DRC and surrounding countries at the American Society of Tropical Medicine and Hygiene (ASTMH) conference.
First Year Of Impact 2016
Sector Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology
Impact Types Policy & public services

 
Description Results relayed to World Health Organisation (WHO) Malaria Policy Advisory Committee (MPAC), leading to new position document on malaria rapid diagnostic tests.
Geographic Reach Multiple continents/international 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
URL http://www.who.int/malaria/mpac/mpac-sept2016-hrp2-consultation-short-report-session7.pdf?ua=1
 
Description SpaPfalGen working group on spatial P. falcparum genetic analysis approaches 
Organisation Broad Institute
Country United States 
Sector Charity/Non Profit 
PI Contribution I am one of five key members in the organising committee of this flexible working group focusing on spatial aspects of malaria genetic analysis. I have been involved in key strategic decisions around the objectives and scope of this group going forward, including potential ways of seeking future funding. I have presented my work on multiple occasions and have contributed to the discussion around others' work. Finally, I was an author on our first joint publication to emerge from this group.
Collaborator Contribution We have regular meetings in which new results and analysis tools are presented for discussion, and we make plans for how we can help in each other's research. My collaborators in this group have been key in formulating analysis ideas and improving software methods for interpreting the signal in genetic data. I am confident this will be a longstanding and fruitful collaboration, ultimately leading to future grants, papers and software tools.
Impact BMC medicine paper on "Mapping malaria by combining parasite genomic and epidemiologic data".
Start Year 2018
 
Description SpaPfalGen working group on spatial P. falcparum genetic analysis approaches 
Organisation Harvard University
Department Harvard T.H. Chan School of Public Health
Country United States 
Sector Academic/University 
PI Contribution I am one of five key members in the organising committee of this flexible working group focusing on spatial aspects of malaria genetic analysis. I have been involved in key strategic decisions around the objectives and scope of this group going forward, including potential ways of seeking future funding. I have presented my work on multiple occasions and have contributed to the discussion around others' work. Finally, I was an author on our first joint publication to emerge from this group.
Collaborator Contribution We have regular meetings in which new results and analysis tools are presented for discussion, and we make plans for how we can help in each other's research. My collaborators in this group have been key in formulating analysis ideas and improving software methods for interpreting the signal in genetic data. I am confident this will be a longstanding and fruitful collaboration, ultimately leading to future grants, papers and software tools.
Impact BMC medicine paper on "Mapping malaria by combining parasite genomic and epidemiologic data".
Start Year 2018
 
Description SpaPfalGen working group on spatial P. falcparum genetic analysis approaches 
Organisation Johns Hopkins University
Department Johns Hopkins Bloomberg School of Public Health
Country United States 
Sector Academic/University 
PI Contribution I am one of five key members in the organising committee of this flexible working group focusing on spatial aspects of malaria genetic analysis. I have been involved in key strategic decisions around the objectives and scope of this group going forward, including potential ways of seeking future funding. I have presented my work on multiple occasions and have contributed to the discussion around others' work. Finally, I was an author on our first joint publication to emerge from this group.
Collaborator Contribution We have regular meetings in which new results and analysis tools are presented for discussion, and we make plans for how we can help in each other's research. My collaborators in this group have been key in formulating analysis ideas and improving software methods for interpreting the signal in genetic data. I am confident this will be a longstanding and fruitful collaboration, ultimately leading to future grants, papers and software tools.
Impact BMC medicine paper on "Mapping malaria by combining parasite genomic and epidemiologic data".
Start Year 2018
 
Description SpaPfalGen working group on spatial P. falcparum genetic analysis approaches 
Organisation University of California, San Francisco
Department School of Medicine (UCSF)
Country United States 
Sector Academic/University 
PI Contribution I am one of five key members in the organising committee of this flexible working group focusing on spatial aspects of malaria genetic analysis. I have been involved in key strategic decisions around the objectives and scope of this group going forward, including potential ways of seeking future funding. I have presented my work on multiple occasions and have contributed to the discussion around others' work. Finally, I was an author on our first joint publication to emerge from this group.
Collaborator Contribution We have regular meetings in which new results and analysis tools are presented for discussion, and we make plans for how we can help in each other's research. My collaborators in this group have been key in formulating analysis ideas and improving software methods for interpreting the signal in genetic data. I am confident this will be a longstanding and fruitful collaboration, ultimately leading to future grants, papers and software tools.
Impact BMC medicine paper on "Mapping malaria by combining parasite genomic and epidemiologic data".
Start Year 2018
 
Description SpaPfalGen working group on spatial P. falcparum genetic analysis approaches 
Organisation University of North Carolina at Chapel Hill
Department UNC Research
Country United States 
Sector Academic/University 
PI Contribution I am one of five key members in the organising committee of this flexible working group focusing on spatial aspects of malaria genetic analysis. I have been involved in key strategic decisions around the objectives and scope of this group going forward, including potential ways of seeking future funding. I have presented my work on multiple occasions and have contributed to the discussion around others' work. Finally, I was an author on our first joint publication to emerge from this group.
Collaborator Contribution We have regular meetings in which new results and analysis tools are presented for discussion, and we make plans for how we can help in each other's research. My collaborators in this group have been key in formulating analysis ideas and improving software methods for interpreting the signal in genetic data. I am confident this will be a longstanding and fruitful collaboration, ultimately leading to future grants, papers and software tools.
Impact BMC medicine paper on "Mapping malaria by combining parasite genomic and epidemiologic data".
Start Year 2018
 
Title MALECOT - R package for inferring population structure from genetic data 
Description Although many programs exist for detecting structure in genetic data, these are not geared up for the types of poly-clonal data common in malaria application, in which a single individual may harbor multiple different strains of parasite. The MALECOT software solves this problem by building on previous modelling work to address poly-clonality directly within a Bayesian statistical framework. 
Type Of Technology Software 
Year Produced 2018 
Open Source License? Yes  
Impact This software has been utilised by researchers in several institutions, including (that I am aware of) the University of North Carolina at Chapel Hill and the London School of Hygeine and Tropical Medicine. In both cases I have received good feedback that the program performed well and aided in their research goals. 
URL https://bobverity.github.io/MALECOT/
 
Title MIPanalyzer - R package for analysing molecular inversion probe data 
Description Molecular Inversion Probe (MIP) data is a form of targetted amplicon genetic data that is increasingly used in malaria genetic analyses. As with any sequencing approach, MIP data requires its own custom filtering and analysis tools to get the most out of the data. The MIPanalyzer program makes it straightfoward to analyze MIP data and to visualise results. 
Type Of Technology Software 
Year Produced 2019 
Open Source License? Yes  
Impact This software package was used in our Nature Communications paper based on MIP data (https://doi.org/10.1038/s41467-020-15779-8) and continues to be an important part of the suite of analysis tools used by researchers at the University of North Caroline at Chapel Hill. 
URL https://mrc-ide.github.io/MIPanalyzer/index.html
 
Description Conference presentation - American Society of Tropical Medicine and Hygiene (ASTMH) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Gave talk at ASTMH conference on "Variation at the var2csa locus: Results from a cross-sectional study in the Democratic Republic of the Congo". This talk sparked further dialogue with researchers looking into genetic methods, and was also published in the Malaria Journal.
Year(s) Of Engagement Activity 2017
 
Description GEM conference talk on MALECOT software for detecting population structure 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Conference talk as part of the Genomic Epidemiology of Malaria (GEM) conference, 2018. Presented work on my software package "MALECOT" for identifying sub-populations from Plasmodium genetic information. Generated considerable interest among the research community.
Year(s) Of Engagement Activity 2018
URL https://bobverity.github.io/MALECOT/
 
Description Imperial Festival Infectious Diseases stand 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Each year, the department of infectious diseases runs stalls and activities as part of the wider Imperial Festival. These activities include a simulation demonstrating how vaccines work, top-trumps cards to give out, and a game for younger children involving matching diseases and vectors. This event reached many hundreds of children and adults over the course of the festival. As one of the many volunteers in this years festival I had interesting and fruitful conversations with prospective students and parents, and hopefully inspired more students to think about infectious disease modelling as a future career.
Year(s) Of Engagement Activity 2017
URL http://www.imperial.ac.uk/festival/
 
Description Invited speaker - UNC medical seminar 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact Invited speaker during UNC visit, gave seminar as part of weekly series. Focused on spatial targeting methods for infectious diseases, in particular malaria. This led to close collaboration with Ross Boyce - a researcher at UNC interested in applying these methods prospectively to a field site in Western Uganda. Ross is currently writing up this research plan as a K-award grant application, which I am contributing to.
Year(s) Of Engagement Activity 2017
URL https://evolve.sbcs.qmul.ac.uk/lecomber/sample-page/geographic-profiling/